Skip to content
Parakho

Q1 FY27, unaudited

Revenue
₹483.60 Cr
Profit after tax
₹66.50 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations483.60+29.51%1,701.50
Other income30.70+151.64%56.60
Total income514.30+33.38%1,758.10
Employee benefit expense84.90+24.49%290.70
Finance costs32.80+162.40%78.70
Depreciation & amortisation27.30+56.00%86.10
Total expenses425.50+39.10%1,398.40
Profit before tax88.80+11.42%352.70
Tax expense22.30+6.70%92.00
Profit after tax66.50+13.10%260.70
Total comprehensive income66.50+13.68%260.70
Earnings per share
Earnings per share, basic₹1.66₹6.52
Earnings per share, diluted₹1.66₹6.52

Q1 FY27 unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base unaudited, from the company’s filing with NSE. Source

FY26 from the company’s filing with NSE. Source

Earnings call

Q1 FY27

KIMS Hospitals reported Q1 FY'27 total revenue of Rs 1,196 crore, up 36.1% year-on-year, with EBITDA of Rs 240 crore and PAT of Rs 37 crore. The company completed a Rs 1,500 crore QIP and a Rs 600 crore preferential allotment to promoters, using Rs 1,100 crore of proceeds to reduce debt. Management discussed the ramp-up trajectory of newly commissioned hospitals in Kondapur, Thane, Nashik and Bangalore, along with occupancy levels, ARPOB trends, and empanelment progress across clusters.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 56 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 20 Aug 2026.